Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sodium Glucose Co-Transporter 2 Inhibitors”

37 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 37 results

Large-scale testing (Phase 3)Study completedNCT07344922
What this trial is testing

SGLT2 Inhibitors in Non-Diabetic CKD: Effects on Vascular Calcification and Anemia

Who this might be right for
Chronic Kidney DiseaseAnemiaCardiovascular Calcification
Mansoura University 100
Post-approval studies (Phase 4)UnknownNCT02528019
What this trial is testing

Metabolic and Cardiovascular Effects of Dipeptidyl Peptidase-4 (DPP-4) or Sodium-glucose Co-transporter Type 2 (SGLT2) Inhibitors

Who this might be right for
Effects of the DPP-4 Inhibitors or SGLT2 Inhibitors on the Protective Actions for Diabetic Complications
Kurume University 100
Not applicableStudy completedNCT06000722
What this trial is testing

SGLT-i Use in Diabetic Foot Ulcer Disease

Who this might be right for
Diabetic Foot Ulcer
University of Leicester 21
Post-approval studies (Phase 4)Study completedNCT05278962
What this trial is testing

HF Patients With LVADs Being Treated With SGLT2i

Who this might be right for
Heart Failure With Reduced Ejection Fraction
University of Chicago 32
Very early researchLooking for participantsNCT06430684
What this trial is testing

Feasibility Trial of Sodium-GLucose coTransporter 2 INhibitors in Pediatric Chronic KIDney DiSease

Who this might be right for
Chronic Kidney DiseasesPediatric Kidney Disease
Ann & Robert H Lurie Children's Hospital of Chicago 40
Post-approval studies (Phase 4)Study completedNCT03226457
What this trial is testing

SGLT2 Inhibition in Combination With Diuretics in Heart Failure

Who this might be right for
Heart FailureType 2 Diabetes Mellitus
University of Dundee 23
Post-approval studies (Phase 4)UnknownNCT03573102
What this trial is testing

Effect of Sodium Glucose co Transporter 2 Inhibitor ( SGLT2) on Proteinuria in Diabetic Patients

Who this might be right for
Diabetic Nephropathies
Nahla H Tohami 60
Post-approval studies (Phase 4)Looking for participantsNCT07405216
What this trial is testing

Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Adolescents With Early Stages of Chronic Kidney Disease

Who this might be right for
Chronic Kidney Disease (Mild to Moderate)AlbuminuriaAdolescent+1 more
Centenario Hospital Miguel Hidalgo 200
Post-approval studies (Phase 4)Ended earlyNCT05346653
What this trial is testing

The Hemodynamic Effects of SGLT2i in Acute Decompensated Heart Failure

Who this might be right for
Acute Decompensated Heart Failure
University of Chicago 1
Not applicableStudy completedNCT06902493
What this trial is testing

Impact of Prior SGLT2 Inhibitors Use on the Development and Progression of Sepsis-Associated Acute Kidney Injury

Who this might be right for
SepsisSeptic ShockAcute Kidney Injury
University of Jazan 664
Large-scale testing (Phase 3)Looking for participantsNCT05345327
What this trial is testing

SGLT2 Inhibitors As First Line Therapy to Prevent Renal Decline in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
The George Institute 994
Post-approval studies (Phase 4)WithdrawnNCT04531397
What this trial is testing

Efficacy and Safety of Dapagliflozin in Children With Proteinuric Chronic Kidney Disease

Who this might be right for
ProteinuriaChronic Kidney Diseases
Children's Hospital of Fudan University
Very early researchUnknownNCT04806633
What this trial is testing

Dapagliflozin to Prevent the Incidence of Contrast Induced Nephropathy After Heart Catheterization and Percutaneous Coronary Intervention

Who this might be right for
Left Cardiac CatheterizationPercutaneous Coronary InterventionAcute Kidney Injury+1 more
G.Gennimatas General Hospital 1,722
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06072326
What this trial is testing

DApagliflozin SC0062 and Prevention of Renal Injury; a Randomized Evaluation

Who this might be right for
Type 1 Diabetes Mellitus With Diabetic Nephropathy
University Medical Center Groningen 36
Not applicableUnknownNCT05993897
What this trial is testing

Effect of Sodium Glucose Co-transporter 2 Inhibitors on Left Atrial Remodeling

Who this might be right for
Atrial Fibrillation
Aswan University 60
Not applicableStudy completedNCT03741972
What this trial is testing

Metabolic and Hemodynamic Effects of the Inhibitors of Type 2 Sodium Glucose Co-transporters (ISGLT2) in Diabetic Patients With Heart Failure

Who this might be right for
Heart Failure
Germans Trias i Pujol Hospital 100
Not applicableStudy completedNCT02636192
What this trial is testing

Study on Incidence of Diabetic Ketoacidosis Among Participants With Type 2 Diabetes Mellitus Treated With Sodium-glucose Co-transporter 2 (SGLT2) Inhibitors or Other Antihyperglycemic Agents

Who this might be right for
Diabetes Mellitus, Type 2
Janssen Research & Development, LLC 200,000
Not applicableUnknownNCT03917758
What this trial is testing

Antidiuretic Function Before and During Treatment With SGLT2 Inhibitors

Who this might be right for
Diabetes Mellitus, Type 2Arterial HypertensionBody Weight Changes
University of Turin, Italy 30
Large-scale testing (Phase 3)UnknownNCT05373004
What this trial is testing

Comparison Between the Efficacy of SGLT2 Inhibitor Therapy Versus ACE Inhibitor in the Treatment of Diabetic Kidney Disease

Who this might be right for
Diabetic Nephropathy Type 2
Omar Tarek Elfarargi 212
Post-approval studies (Phase 4)Looking for participantsNCT06249945
What this trial is testing

EMPAgliflozin in Heart Failure With PReserved Ejection Fraction and End Stage Renal Disease

Who this might be right for
Heart Failure With Preserved Ejection FractionEnd Stage Renal Disease on Dialysis
National Taiwan University Hospital 150
Load More Results